Sunday, June 14, 2026

Latest

Green Thumb: Fourth Quarter Analyst Consensus Estimates

Green Thumb Industries (CSE: GTII) announced that they will be reporting their fourth quarter and year end financials after hours on March 17th. Analysts have a consensus C$49.69 12-month price target on the company, via a total of 14 analysts, with three analysts having a strong buy rating and the other 11 have buy ratings. The street high comes from BTIG with a C$73 price target, and the lowest target comes from Beacon Securities with a C$33 price target.

Fourteen analysts have revenue estimates for the fourth quarter. The mean between all 14 is U$167.2 million; this number has been revised upwards from U$166.47 million at the start of the year. BTIG currently has the highest revenue estimate with U$183.50 million, while the lowest comes from Benchmark with a U$152 million estimate.

For the full year, the average revenue estimate between 14 analysts is currently U$549.81 million. This number has been revised upwards from U$548.98 million at the start of the year. The street high comes from Cormark with a U$564.7 full-year revenue estimate.

Onto EBITDA estimates, there are currently 12 analysts who have fourth-quarter EBITDA estimates. The mean is currently U$57.42 million, with this number being revised upwards from U$55.63 million at the start of the year. Street high goes to BITG with a U$72.80 million EBITDA estimate and the lowest being Benchmark with a U$44 million estimate.

For the full year, the current EBITDA mean across 13 analysts is U$172.17 million. This number has been revised upwards from U$170.91 million at the start of the year. BITG currently has the highest full-year estimate at U$187 million and the lowest being Benchmark with a U$158 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Canadian Dream Is Leaving Canada | Spencer Gatten

Allied Gold: The Zijin Deal Is On The Rocks

Why Silver’s Drop May Not Mean the Bull Market Is Over | Peter Krauth

Recommended

Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project

Blue Jay Gold Launches 16,000 Metre Drill Program At Steller

Related News

BMO Upgrades AngloGold To Outperform, Raises Price Target To $36

This morning, BMO Capital Markets upgraded AngloGold Ashanti (NYSE: AU) to outperform and upgraded their...

Tuesday, December 8, 2020, 11:34:03 AM

Cresco Labs: Consensus First Quarter 2021 Estimates

Cresco Labs (CSE: CL) announced that they will be reporting their first quarter financials before...

Tuesday, May 25, 2021, 11:51:00 AM

BMO Raises Jazz Pharmaceuticals Price Target To US$205

It was announced last week wednesday that Jazz Pharmaceuticals (NASDAQ: JAZZ) would be acquiring GW...

Monday, February 8, 2021, 10:40:00 AM

MediPharm Labs: Canaccord Slashes Price Target Following Q4 Results

Earlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial...

Friday, April 2, 2021, 09:00:00 AM

Valens: Second Quarter Consensus Estimates

The Valens Company (TSX: VLNS) announced that they will be reporting their second quarter financials...

Tuesday, July 13, 2021, 02:30:00 PM